Brian Gentry
Associate Professor of Pharmacology
Pharmaceutical & Admin. Sciences
Drake University College of Pharmacy and Health Sciences
United States of America
Biography
Dr. Brian Gentry received his Ph.D. from the University of Michigan (USA). He is currently working as an Associate Professor of Pharmacology. His research focuses on development of novel, experimental therapeutics, Current efforts are focused on the development of a multi-drug regimen for the treatment of HCMV, determining the extent of in vivo metabolism for these drugs, and elucidating the molecular mechanism of action for each of these compounds. In the past few years, he has been becoming one of leading experts in Pharmacology. He has also serving Archive Committee Chair and Poster Judging Committee at ISAR. Dr. Gentry has co-authored various journal papers.
Research Interest
Development of novel, Experimental therapeutics; Development of a multi-drug regimen for the treatment of HCMV
Publications
-
Gentry BG, Gentry SN, Jackson TL, Zemlicka J, Drach JC (2011) Phosphorylation of Antiviral and Endogenous Nucleotides to Di- and Triphosphates by Guanosine Monophosphate Kinase. Biochem Pharma 81: 43-49.
-
Gentry BG, Drach JC (2014) Metabolism of Cyclopropavir and Ganciclovir in Human Cytomegalovirus Infected Cells. Antimicro Agent Chemo 58: 2329-2333.
-
Gentry BG, Vollmer LE, Hall ED, Borysko KZ, Kamil JP, et al. (2013) Resistance of Human Cytomegalovirus to Cyclopropavir Maps to a Base Pair Deletion in the Open Reading Frame of UL97. Antimicro Agent Chemo 57: 4343-4348.
